In patients with severe renal dysfunction given idarucizumab, “be alert for a recurrent bleed,” which could require a second dose of idarucizumab, Dr. Eikelboom suggested.
SOURCE: Eikelboom JW et al. ACC 18, Abstract 1231M-11.
Conference Coverage
Impaired kidney function no problem for dabigatran reversal
Publish date: April 23, 2018
REPORTING FROM ACC 18